Topical ropivacaine hydrochloride 0.5% and lidocaine hydrochloride 2% significantly reduce corneal sensitivity without short‐term negative side effects in horses
Veterinary Ophthalmology · 2023
DOI: 10.1111/vop.13137 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary Ophthalmology, 2023. Verfasst von Michael P Minaldi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, College of Veterinary Medicine, Mississippi State University, Mississippi State, Mississippi, USA. Hauptthemen laut MEDLINE: Lidocaine, Anesthetics, Local. Die Arbeit nennt 24 Literaturangaben. Gefördert von: ACVO Vision for Animals Foundation, College of Veterinary Medicine, Mississippi State University.
Abstract (Originalsprache)
Objective
To evaluate corneal sensitivity and acute side effects following application of ropivacaine hydrochloride 0.5% and lidocaine hydrochloride 2% on the healthy equine cornea. Animals Studied Eight healthy adult horses. Procedure A randomized, masked, crossover study design was utilized. Baseline Semiquantitative Preclinical Ocular Toxicology (SPOT) scores and corneal touch thresholds (CTT) using a Cochet‐Bonnet esthesiometer were recorded and measured, respectively, for eight healthy adult horses before medication application. Commercially available eyewash was used as a negative control. Ropivacaine hydrochloride 0.5% or lidocaine hydrochloride 2% solution was sprayed on a randomly selected eye, and the contralateral eye received eyewash. CTT was measured in both eyes at 1, 5, 15, 25, 35, 45, 55, 65, and 75 min post‐application. Post‐application SPOT scores were recorded immediately following the trial. Linear mixed model statistical analyses (mean ± standard error) were performed ( p < .05).
Results
Mean eyewash CTT (3.41 cm ± 0.464) was significantly different from ropivacaine‐treated (1.44 cm ± 0.562) ( p = .008) and lidocaine‐treated eyes (1.75 cm ± 0.562) ( p = .024); CTT was not significantly different between drug groups ( p = .88). Time to maximum anesthesia was not significantly different between ropivacaine (13.25 min ± 3.353) and lidocaine (16.25 min ± 3.353) ( p = .40). No side effects were appreciated as confirmed by SPOT.
Conclusions
Ropivacaine and lidocaine similarly decreased corneal sensitivity when applied topically without clinically evident short‐term ocular side effects. Lidocaine may be preferable in clinical settings due to its large, multi‐use vials and similar effects to ropivacaine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Sciences, College of Veterinary Medicine, Mississippi State University, Mississippi State, Mississippi, USA.
- College of Veterinary Medicine, Mississippi State University, Mississippi State, Mississippi, USA.
- Department of Pathobiology and Population Medicine, College of Veterinary Medicine, Mississippi State University, Mississippi State, Mississippi, USA.
ORCID-Profile: Michael P Minaldi, Caroline M Betbeze, Mary R Telle
Förderung
- ACVO Vision for Animals Foundation
- College of Veterinary Medicine, Mississippi State University
Zitieren
APA
Minaldi, M. P., Fidler, L. E., Betbeze, C. M., Wills, R., Fontenot, R. L., & Telle, M. R. (2023). Topical ropivacaine hydrochloride 0.5% and lidocaine hydrochloride 2% significantly reduce corneal sensitivity without short‐term negative side effects in horses. Veterinary Ophthalmology. https://doi.org/10.1111/vop.13137
Vancouver
Minaldi MP, Fidler LE, Betbeze CM, Wills R, Fontenot RL, Telle MR. Topical ropivacaine hydrochloride 0.5% and lidocaine hydrochloride 2% significantly reduce corneal sensitivity without short‐term negative side effects in horses. Veterinary Ophthalmology. 2023. doi:10.1111/vop.13137
BibTeX
@article{Minaldi2023,
author = {Minaldi, Michael P and Fidler, Laura E and Betbeze, Caroline M and Wills, Robert and Fontenot, Robin L and Telle, Mary R},
title = {Topical ropivacaine hydrochloride 0.5% and lidocaine hydrochloride 2% significantly reduce corneal sensitivity without short‐term negative side effects in horses},
journal = {Veterinary Ophthalmology},
year = {2023},
doi = {10.1111/vop.13137}
}
EUVIMED